Spotlight on $SINT and $MYNZ: Oncology Leaders$SINT’s push into innovative cancer treatment devices positions it well in the booming oncology space. $MYNZ complements this with cutting-edge diagnostics, addressing early detection needs. Strong market fundamentals support long-term value for both.